Saltar al contenido
Merck

Desferrioxamine-caffeine (DFCAF) as a cell permeant moderator of the oxidative stress caused by iron overload.

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine (2014-10-01)
Elizabeth Carmen Pastrana Alta, Dibakar Goswami, M Teresa Machini, Daniel Menezes Silvestre, Cassiana Seimi Nomura, Breno Pannia Espósito
RESUMEN

Desferrioxamine (DFO) is a potent iron chelator used in the treatment of iron overload (IO) disorders. However, due to its low cell permeability and fast clearance, DFO administration is usually prolonged and of limited use for the treatment of IO in tissues such as the brain. Caffeine is a safe, rapidly absorbable molecule that can be linked to other compounds to improve their cell permeability. In this work, we successfully prepared and described DFO-caffeine, a conjugate with iron scavenging ability, antioxidant properties and enhanced permeation in the HeLa cell model.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Ácido trifluoroacético, ReagentPlus®, 99%
Sigma-Aldrich
Ácido trifluoroacético, suitable for HPLC, ≥99.0%
Sigma-Aldrich
Ácido trifluoroacético, puriss. p.a., suitable for HPLC, ≥99.0% (GC)
Sigma-Aldrich
Deferoxamine mesylate salt, ≥92.5% (TLC), powder
Sigma-Aldrich
Ácido trifluoroacético, ≥99%, for protein sequencing
Sigma-Aldrich
Calcein-AM, suitable for fluorescence, BioReagent, ≥95.0% (HPLC)
Supelco
Ácido trifluoroacético, analytical standard
Sigma-Aldrich
Calcein-AM, Small Package (20 X 50 μg ), ≥95.0% (HPLC)
Sigma-Aldrich
Calcein AM solution, 4 mM in DMSO, ≥90% (HPLC), solution
Deferoxamine mesylate salt, European Pharmacopoeia (EP) Reference Standard